Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2012
03/21/2012CN102388044A Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/21/2012CN102388043A Histamine h3 inverse agonists and antagonists and methods of use thereof
03/21/2012CN102388029A Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/21/2012CN102388025A Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
03/21/2012CN102382129A Spirocycles-substituted phosphodiesterase inhibitor
03/21/2012CN102382117A Novel preparation method for 5,15-dialkyl substituent porphyrin and application thereof to field of photoelectric devices
03/21/2012CN102382116A Synthesis technology and equipment of tetraaryl cobalt porphyrin
03/21/2012CN102382115A Synthetic method of indazole-phthalazine compound
03/21/2012CN102382114A Method for simultaneously preparing heliotrine and lasiocarpine
03/21/2012CN102382106A Aniline substituted quinazoline derivative
03/21/2012CN101386783B Sulfotetraphenyl porphyrin nano luminescent material and preparation method thereof
03/21/2012CN101318963B Method for preparing sudroma, leaf protein and feedstuff additive with fresh leaf juice of sisal, agave hemp
03/20/2012US8138337 Reverse-turn mimetics and method relating thereto
03/20/2012US8138336 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
03/20/2012US8138333 Sulfonyl-indole derivatives
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8138194 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
03/20/2012CA2641976C Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2524900C 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
03/15/2012WO2012034095A1 Compounds and compositions as trk inhibitors
03/15/2012WO2012034091A1 Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
03/15/2012WO2012034066A1 Broadly absorbing metalloporphyrin-based multichromophoric arrays for triplet harvesting
03/15/2012WO2012033735A1 Inhibitors of human immunodeficiency virus replication
03/15/2012WO2012033548A2 Herbicidal bis-nitrogen-containing oxo and sulfono heterocycles
03/15/2012WO2012033101A1 Quinoxaline compound
03/15/2012WO2012032031A1 Substituted imidazopyridazines
03/15/2012WO2011163430A9 Polymorphs of osi-906
03/15/2012WO2011147951A8 Cycloamino derivatives as gpr119 agonists
03/15/2012WO2011079935A3 A process for the preparation and isolation of vardenafil and salts thereof
03/15/2012US20120065366 Cyclic amino acid molecules and methods of preparing the same
03/15/2012US20120065233 Tyrosine kinase inhibitors
03/15/2012US20120065217 Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
03/15/2012US20120065210 Substituted hexahydropyrrolo[1,2-c]imidazolones
03/15/2012US20120065209 TETRAHYDRO-IMIDAZO[1,5-a]PYRAZINE DERIVATIVES SALTS, PREPARATION METHODS AND MEDICINAL USE THEREOF
03/15/2012US20120065202 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
03/15/2012US20120065201 Inhibitors of bruton's tyrosine kinase
03/15/2012US20120065190 Benzazepine compounds as cgrp receptor antagonists
03/15/2012US20120065187 Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/15/2012US20120065184 Compounds and compositions as trk inhibitors
03/15/2012US20120065154 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof
03/15/2012CA2812979A1 Broadly absorbing metalloporphyrin-based multichromophoric arrays for triplet harvesting
03/15/2012CA2810858A1 Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
03/15/2012CA2810755A1 Substituted imidazopyridazines
03/15/2012CA2810659A1 Quinoxaline compound
03/14/2012EP2427573A2 Method of oligonucleotide labeling using cycloaddition reaction
03/14/2012EP2427454A1 Phenoxymethyl heterocyclic compounds
03/14/2012EP2427451A1 Alpha helix mimetics and methods relating thereto
03/14/2012EP2427444A1 Inhibitors of the renal outer medullary potassium channel
03/14/2012EP2427431A1 Novel indicator platform
03/14/2012EP2152714B1 SPIROINDOLINONE DERIVATIVES AS MDM2-p53 INHIBITORS
03/14/2012EP2106401B1 Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof
03/14/2012EP1971608B1 Spiroketals
03/14/2012EP1667685B1 Quinazoline potassium channel inhibitors
03/14/2012EP1501897B1 Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides
03/14/2012CN102378759A Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/14/2012CN102378739A Method for preparing cha-type molecular sieves using novel structure directing agents
03/14/2012CN102372719A Pemetrexed methyl ester p-toluenesulfanate crystal form and preparation method thereof
03/14/2012CN102372718A Pyridyl-contained dicarbazole compound and application thereof
03/14/2012CN102372717A Pyrrolopyrimidine compound and use thereof
03/14/2012CN102372716A Phthalazone derivative, its preparation method and application in medicine thereof
03/14/2012CN102372706A Phthalazinone derivative, its preparation method and application in medicament
03/14/2012CN102372698A Phthalazinone derivative and its preparation method and use in medicine
03/14/2012CN102372692A Dihydropyridine derivative
03/13/2012US8134012 A carboxamide such as N-[2-(1,3-dimethylbutyl)phenyl]-2-iodobenzamide or 5-fluoro-1,3-dimethyl-N-[2-(1,3,3-trimethylbutyl)phenyl]-1H-pyrazole-4-carboxamide in combination with tolclofos-methyl and/or flutolanil; use against phytopathogenic fungi; treating transgenic plants or seeds
03/13/2012US8133997 2,4-dioxopyrimidine-based mesoionic pigments
03/13/2012US8133996 Process for the preparation of ethyl-N-(2,3-dichloro-6-nitrobenzyl)glycine hydrochloride
03/13/2012US8133995 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/13/2012US8133992 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
03/13/2012US8133899 Pyrrolo[2,3-d]pyrimidine compounds
03/13/2012US8133897 Phenylimidazole derivatives as PDE10A enzyme inhibitors
03/13/2012US8133474 Porphyrin chelate compound that may be complexed with zinc, manganese, magnesium, iron or aluminum; capable of insertion into cell; zinc, calcium, mercury, cadmium, and lead analytes; determining shift in signal; medical diagnosis
03/13/2012US8133473 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/13/2012CA2704815C Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein
03/13/2012CA2663175C Kinase inhibitor
03/13/2012CA2524344C Pyrazolo [4, 3-d]pyrimidines, process for their preparation and methods of use
03/13/2012CA2330492C Novel octahydro-6,10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds
03/08/2012WO2012031140A1 Adsorption of immunopotentiators to insoluble metal salts
03/08/2012WO2012031004A1 Pyridinones/pyrazinones, method of making, and method of use thereof
03/08/2012WO2012030990A1 Pyridazinones, method of making, and method of use thereof
03/08/2012WO2012030924A1 Azolopyridine and azolopyrimidine compounds and methods of use thereof
03/08/2012WO2012030170A2 Novel compound acting as a cannabinoid receptor-1 inhibitor
03/08/2012WO2012028647A1 Bicyclic aza heterocycles, and use thereof
03/08/2012WO2012028331A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012WO2012028243A1 Pyrazolopyridinone derivatives as lpa receptor antagonists
03/08/2012WO2012027960A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof
03/08/2012WO2010129864A9 Methods and compositions for studying, imaging, and treating pain
03/08/2012WO2010094126A8 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/08/2012US20120059164 PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
03/08/2012US20120059162 Fused imidazole derivative having ttk inhibitory action
03/08/2012US20120059140 Diketopyrrolopyrrole polymers for use in organic semiconductor devices
03/08/2012US20120059018 Novel chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same
03/08/2012US20120059010 Alpha-helix mimetics and methods relating to the treatment of fibrosis
03/08/2012US20120059000 Chemical compounds, compositions and methods for kinase modulation
03/08/2012US20120058999 Substituted Tetrahydropyrrolopyrazine Compounds
03/08/2012US20120058997 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
03/08/2012US20120058940 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058939 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058189 Process for making a crystalline zilpaterol salt
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 573